Login/Register

News

GNT Biotech and Medicals Corporation (GNTbm) completes series B and accelerates new drug GNTbm-38 to enter IND by the end of next year

GNTbm expects to complete the API, formulation, pharmacokinetics, toxicology pharmacokinetics and safety toxicology next year.

Read more
Nov 03, 2022
TechNews
Nov 03, 2022
Economic Daily
Nov 03, 2022
Nov 02, 2022
Taipei Times
Nov 02, 2022
United Daily
Nov 02, 2022
China Times
Nov 01, 2022
Economic Daily
Nov 01, 2022
InfoTimes
Nov 01, 2022
Senhwa Biosciences